ArticleFrontiers in pharmacology2021

Triazine Derivative as Putative Candidate for the Reduction of Hormone-Positive Breast Tumor:

Muhammad Tayyab Imtiaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.